Table 2.
The clinical data of compensated cirrhosis patients.
| Variables | No. of patients | Mean ± SD | 95% CI |
|---|---|---|---|
| Sex (male/female) | 47/3 | ||
| Age | 45.42 ± 7.86 | 43.19–47.65 | |
| 18–40 | 9 | ||
| 41–60 | 41 | ||
| Stage | |||
| Ishak = F5 | 9 | ||
| Ishak = F6 | 41 | ||
| PLT (*109/L) | 102.68 ± 39.90 | 91.34–114.02 | |
| >100 | 28 | ||
| >60 and <100 | 22 | ||
| ALT | 50 | 39.69 ± 43.63 | 27.28–52.08 |
| TBIL | 50 | 15.94 ± 9.31 | 13.29–18.58 |
| GGT | 50 | 69.40 ± 83.82 | 45.58–93.22 |
| HBV-DNA (IU/ml) | |||
| <20 | 25 | ||
| >20 | 25 | ||
| Diameter of portal vein | 1.23 ± 0.14 | 1.19–1.27 | |
| <1.3 cm | 25 | ||
| >1.3 cm | 25 | ||
| Thickness of spleen | 4.61 ± 1.08 | 4.30–4.92 | |
| >4.0 cm | 31 | ||
| <4.0 cm | 19 |
PLT: blood platelet; HBV: hepatitis B virus.